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ABSTRACT 
The new 7-bromoindirubin-3’-oxime (7BIO) compound induces caspase-independent cell death in all cell 
lines tested to date. Irrespective of the cell line, a 25 µM treatment for 24 hours is lethal for the entire cell 
population. In SH-SY5Y and Jurkat cells, 7BIO (25 µM) was found to collapse the mitochondrial 
transmembrane potential (∆Ψm) at only 2-3 hours of treatment. Concomitantly mitochondria swelled, cristae 
disrupted and, after 9 hours, external cell membranes ruptured. In addition, endoplasmic reticulum dilated 
and, unexpectedly, the acute cytoplasmic destruction yielded isolated nuclei with preserved morphology and 
DNA integrity. Furthermore, the process was independent of both Bax and Bak, since cell viability and ∆Ψm 
decayed indistinguishably in double Bax-/-Bak-/- mouse embryonic fibroblasts (MEFs) and their wild type 
counterparts. Pharmacological inhibition of the mitochondrial permeability transition pore (MPTP) did not 
prevent 7BIO-induced ∆Ψm loss in none of the aforementioned cell lines. Caspase-independent inducers of 
cell death like AIF (Apoptosis Inducing Factor), cathepsins and calpains were not involved. Only the 
chemical inhibitors of serine proteases and, particularly, AEBSF afforded a significant protection thus 
suggesting a process regulated by this type of enzymes. As far as we know, these features are quite unique 
once taken together. Therefore we propose 7BIO is triggering a specific type of necrotic cell death. Finally, 
the cytotoxicity of 7BIO on apoptosis-resistant cells like double Bax-/-Bak-/- MEFs seems of great interest 
envisaging cancer therapy. 
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1. Introduction 
Cell necrobiology has been proposed to be the scientific discipline devoted to the study of the biological 
processes which predispose, precede or accompany cell death, as well as the consequences of cell demise 
for the tissue environment [1]. The impressive development of apoptosis research in the last 15 years has 
masked the lack of knowledge about the processes involved in other types of cell death. Electron 
microscopy studies of embryonic models provided the first hint about the existence of other types of 
programmed cell death [2]. In 2005, a Nomenclature Committee on Cell Death was created and established 
an official classification [3].  This classification was based on morphological features and was further 
complemented by other criteria, like the catabolic enzymes activated in each type of cell death [4]. 
 Apoptosis (Type 1 cell death) and the pathways leading to it remain the most studied subject in cell 
necrobiology. Apoptosis is a complex phenotype of cell death. It results from caspase degradation of 
specific substrates. However, the lack of caspase activation does not necessarily preclude cell death or 
apoptosis. For instance, MCF-7, a human cell line derived from a breast cancer displaying a null expression 
of effector caspase 3, undergoes apoptosis facing typical apoptotic stimuli but with a non-apoptotic, atypical 
phenotype [5]. Autophagy (Type 2 cell death) has only recently entered and broadened the field of cell 
death. However, in addition to its killing role, autophagy is also a mechanism of survival for cells facing 
conditions such as starvation or hormone deprivation [6]. The resulting ambiguity is not an issue easy to 
solve and has prompted the proposal to define autophagic cell death as any death process with autophagic 
features but not necessarily autophagy being the cause of cell death [3]. Finally, necrosis (Type 3 cell 
death) and mitotic catastrophe ended the official classification [3, 4]. Necrosis has become a synonym of 
acute or accidental type of cell death. In other words, a scenario of cell homeostasis overwhelmed by one 
stressing stimulus or a combination of them. However, necrosis has also been observed to occur in a less 
acute and molecularly regulated way [7-10] Therefore, necrosis is presently an ill-defined term. 
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 Upon the discovery of the anti-leukemia properties of the indirubins contained in a traditional 
Chinese recipe, Danggui Longhui Wan [11], the synthesis and study of these compounds has become an 
active research area. Several protein kinases have been identified as targets of indirubins: CDKs [12], GSK-
3 [13] and others [14]. The bis-indole chemistry of indirubins provides a kinase inhibitor scaffold susceptible 
to chemical modification. As a consequence, new indirubin derivatives can be generated in order to obtain 
more selective or biologically interesting compounds. Several bromo-substituted indirubin-3'-oxime 
derivatives were synthesized and their inhibition profile on 85 protein kinases determined [14]. In this study, 
7BIO proved to be fast and effective at inducing cell death in SH-SY5Y, a human neuroblastoma-derived 
cell line. In addition, the cell death process did not display any of the typical features of apoptosis. For 
example, the internuclesosomal DNA degradation, the nuclear pattern of chromatin condensation or the 
release of cytochrome c from mitochondria, were not observed. Consistently, no activation of effector 
caspases was detected and neither Bcl-2 nor Bcl-XL overexpression afforded any protection to cells treated 
with 7BIO. The caspase-independent process of cell death was also detected in other human cell lines, like 
neuroblastic IMR-5 and IMR-32, hematological HL-60 and Jurkat, etc. 
 In the present report, our purpose has been to progress in the characterization of the cell death 
process triggered by 7BIO. We have demonstrated 7BIO induces a necrotic type of cell death characterized 
by early mitochondrial swelling and further cytoplasm disintegration. The involvement of proteins like 
calpains, cathepsins, Bax, Bak and AIF (Apoptosis Inducing Factor) has been discarded. Moreover, 
pharmacological inhibitors of the mitochondrial permeability transition pore (MPTP) have failed to prevent 
7BIO-induced cell death and the early loss of mitochondrial transmembrane potential (∆Ψm). Finally, a 
pharmacological screening has suggested serine proteases could be regulating the death process. 
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2. Materials and Methods 
2.1. Chemical reagents 
CellTiter 96® kit containing the MTS reagent and Cytotox 96® kit for LDH determinations were provided by 
Promega Biotech Ibérica, SL (Barcelona, Spain). 5BIO (5- bromoindirubin-3’-oxime) and 7BIO (7-
bromoindirubin-3’-oxime) compounds were synthesized in Prof. Skaltsounis' laboratory, University of 
Athens. zVADfmk (z-Val-Ala-Asp-fluoromethylketone), Q-VD-OPh (Q-Val-Asp(non-omethylated)-OPh) and 
AcDEVDafc (Acetyl-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin) were purchased from MP 
Biomedicals Europe (Asse-Relegem, Belgium). 3,3'-dihexyloxacarbocyanine iodide (DiOC6(3)) was 
supplied by Molecular Probes (Europe BV, Leiden, The Netherlands). Leupeptin was purchased from 
Roche (Barcelona, Spain). Cyclosporin A (CsA) and Calpeptin were purchased from Tocris bioscience 
(Bristol, UK). Staurosporine (STS), Bisbenzimide (Hoechst 33342), Bongkrekic acid (BKKA), DCI (3,4-
Dichloroisocoumarin), SuLLVYamc (N-Succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin), Pefabloc® 
SC (AEBSF or 4-(2-amino-ethyl)-benzene-sulfonyl-fluoride), Pepstatin A, PI (Propidium iodide), TPCK (N-p-
Tosyl-L-phenylalanine-chloromethylketone), TLCK (N-α-Tosyl-L-lysine-chloromethylketone hydrochloride), 
zFAfmk (z-Phe-Ala-fluoromethylketone) and zFRamc (z-Phe-Arg-7-amido-4-methylcoumarin hydrochloride) 
were supplied by Sigma (Saint Louis, MO, USA).  Unless otherwise stated, the non-listed reagents were 
also from Sigma. 
 
2.2. Cell culture and chemical treatments 
SH-SY5Y is a cell line derived from the metastasis of a human neuroblastoma. Jurkat, clone E6-1, is a 
human cell line derived from an acute T cell leukemia. Both cell lines were obtained from ATCC (Manassas, 
VA, USA). The immortalized mouse embryonic fibroblasts (MEFs) derived from double Bax-/-Bak-/- null 
mice and their wild type (w.t.) counterparts were gently provided by Dr. S.J. Korsmeyer laboratory [15, 16]. 
MEFs and SH-SY5Y cell lines were grown in 2 mM L-glutamine supplemented DMEM media plus antibiotics 
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and a 10% volume of FCS (Invitrogen, Barcelona, Spain). Jurkat cells were grown in RPMI 1640 media plus 
10% FCS and antibiotics (Invitrogen, Barcelona, Spain). General culturing conditions were 37ºC and a 
water-saturated, 5% CO2 atmosphere. Plates with 6 (M6), 24 (M24) and 96 (M96) wells were used in our 
pharmacological and biochemical determinations. Plates, dishes and other plastic disposable tools for cell 
cultures were supplied by Iwaki (Chiba, Japan), Sarstedt (Newton, NC, USA), Bibby Sterilin (Staffordshire, 
UK) and Becton Dickinson (Franklin Lakes, NJ, USA). 7BIO and 5BIO were dissolved in DMSO at a 
concentration 10 mM. In order to improve 7BIO and 5BIO solubility, stock solutions were heated for 15 
minutes at 60ºC in a sonication bath, previous to their final addition to the culture media. Stock solutions of 
STS, Q-VD-OPh or the other compounds were also prepared with DMSO. From these stock solutions, the 
compounds were delivered to the culture media and adjusted to the final concentrations reported in the text 
and figures. The serial dilution procedure was used in concentration-dependency determinations. DMSO 
concentrations never surpassed 1% in the medium. At this concentration, we have observed no alteration in 
cell viability or differentiation status [17]. 
 
2.3. Flow cytometry 
Flow cytometry analysis was performed on an EPICS XL instrument from Coulter Científica, SA (Madrid, 
Spain), equipped with an Argon ion laser (15 mW, 488 nm) and a standard optical path and filter 
configuration for an analytical cytometer. The green fluorescence (FL1) of DiOC6(3) was collected through 
a 525/20 band pass filter. The red fluorescence (FL3) of PI, for example, was collected through a 620/15 
band pass filter. Typical flow rates were between 150 and 300 cells per second, and a minimum of 10000 
cells were analyzed per sample. Data acquisition was performed using System II (version 3.0) software 
(Coulter Científica, SA, Madrid, Spain). As a trigger signal, forward scatter was used with a threshold at a 
channel 10. Data was stored in list mode files and the subsequent analysis performed by means of the 
System II and the free software developed by Joseph Trotter (WinMDI 2.8). 
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2.4. Quantification of cell death 
Four alternative procedures were performed in order to quantify the ratios of cell death in the culture plates. 
The first one was based on the Trypan Blue dye, which enters and stains those cells with a disrupted 
external membrane. SH-SY5Y cells were preferentially subjected to this procedure along this report.   On 
the other hand, in non-adherent Jurkat cells, staining with PI (25 µg/ml) and flow cytometry was chosen to 
detect and quantify the cells with breaches at the cell membrane. In MEFs and some pharmacological 
screenings we relied on the MTS reduction and the LDH release procedures, which we have described in 
detail before [17]. 
 
2.5. Apoptosis assessment and quantification 
We have used several independent methods to assess and quantify apoptosis in the cell cultures. First, 
nuclear morphology as evidenced by direct 0.05 µg/ml bisBenzimide (Hoechst 33342) staining and 
fluorescence microscopy. Frequently, a double staining with bisBenzimide/PI was performed. In this case, 
PI concentration was 25 µg/ml like above. Second, the generation of large DNA fragments of approximately 
50kbp. This event was evidenced by means of agarose gels run in a contour homogeneous electric field 
(CHEF) system (BioRad, Hercules, CA, USA). The running conditions were 15 hours, at 6 V/cm, initial 
switching time of 50 seconds and final switching time of 90 seconds. Third, the detection of the ladder 
pattern of DNA degradation was done by a standard electrophoresis in 1.5% agarose gels. Fourth, the 
activity of DEVD targeted caspases. The procedure employed was based on reading the fluorescence 
released from an AcDEVDafc substrate after its direct addition to the culture medium, detergent cell lysis 
and incubation at 37°C. All these procedures have been validated and described in our previous works [14, 
17, 18]. 
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2.6. Electron microscopy 
Cells from treated or untreated cultures were collected, washed twice in PBS (150 mM ClNa, 2.7 mM ClK, 8 
mM Na2HPO4, 1.5 mM KH2PO4) and fixed for 30 minutes at 4°C in 100 mM phosphate buffer (pH 7.4) 
containing 2.5% glutaraldehyde. After rinsing the pellets twice with PBS at 4°C, cells were postfixed in 
buffered OsO4, dehydrated in graded acetone and embedded in Durcupan® ACM resin (Fluka, Buchs, 
Switzerland). Ultrathin sections mounted on copper grids were counterstained with uranyl acetate and lead 
citrate. A transmission electron microscope (Zeiss EM 910) was employed to visualize the cellular 
ultrastructure. 
 
2.7. Quantification of mitochondrial ∆Ψm 
SH-SY5Y and Jurkat cells were plated onto M24 plates at a density of 1.5x105 cells/well and MEFs were 
plated onto M6 plates at a density of 2.5x105 cells/well. Following the treatments reported in the text and 
figures, DiOC6(3) reagent was added to the cultures to reach a final concentration of 40 nM. After 
30minutes incubation, cells were harvested and analyzed by flow cytometry, as referred above. In most 
experiments, following an incubation in the DiOC6(3) reagent for 30minutes, PI was added for 15 additional 
minutes. The combined FL1 plus FL3 lectures yielded biparametric plots that allowed the simultaneous 
assessment of ∆Ψm and cell death. 
 
2.8. Protein extraction and Western Blotting 
To study the release of AIF from mitochondria, a 0.05% digitonin cytosolic extraction (Cyt.) was performed 
as we have reported before [17]. The remaining pellet was the mitochondrial containing fraction (Mit.) and 
contained other cells constituents like nuclei. This fraction was subjected to lysis in a buffer containing 100 
mM Tris/ClH pH6.8, 2%SDS, 1 mM EDTA, 1 mM PMSF, 2 µg/ml Aprotinin, 1 µg/ml Leupeptin and 1 µg/ml 
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Pepstatin, by sonication and 5 minutes boiling. Following a centrifugation at 12000 g for 15 minutes the 
extract was obtained. Protein concentration was determined in the extracts by means of the DC Protein 
Assay from BioRad. Volumes were calculated to equalize the protein load in SDS 15% polyacrylamide 
electrophoresis. Following transfer to Nitrocellulose 0.45 µm filters (Schleicher and Schuell, Dassel, 
Germany), membranes were reacted with a dilution 1:40000 of the antiAIF polyclonal antibody (A7549) from 
Sigma. Immunoblots were finally developed with the antirabbit peroxidase conjugate antibody (A0545) from 
Sigma and the SuperSignal West Pico reagent from Pierce (Rockford, IL, USA). Electrophoresis and 
electrotransfer equipments were the MINIPROTEAN III assemblies from BioRad. 
 
2.9. Calpain and cathepsin activity determinations 
Control, untreated, or treated cells were harvested and extracted with a buffer containing 20 mM Tris/ClH 
pH 7.5, 150 mM NaCl, 1% Triton-X-100, 1 mM DTT and 1 mM AEBSF for 10 minutes on ice. After a 
centrifugation at 12000 g for 15 minutes, protein was quantified in the supernatants as previously described 
(DC Protein Assay, BioRad). Equal amounts of protein (20µg) were delivered to the wells of a M96 plate. 
Volumes were equalized with distilled water to 50 µl. If calpain activity was determined, one volume of a 
buffer containing 100 mM Tris/ClH pH  7.5, 16 mM DTT, 20 mM CaCl and 200 µM SuLLVYamc was added. 
If cathepsin activity was determined, one volume of a buffer containing 40 mM Sodium Acetate, 8 mM 
EDTA, 8 mM DTT, 2 mM AEBSF and 200 µM zFRamc (pH6) was added. Then, M96 plates were incubated 
for 5h at 37ºC in the dark and fluorescence (excitation 360/40, emission 460/40) was quantified by means of 
a FL600 plate reader from Biotek Instruments, Inc. (Winooski, VT, USA).  
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3. Results 
3.1. Non-apoptotic, necrotic-like features were found in the cell death process triggered by 7BIO 
In our previous characterization of several indirubin derivatives, we have demonstrated that two related 
compounds 5-bromoindirubin-3'-oxime (5BIO) and 7BIO behaved quite differently at inducing cell death. 
While the former was a caspase-dependent, apoptosis inducer, the latter triggered a caspase-independent 
type of death. Both compounds caused cell-death in a concentration-dependent manner. Irrespective of the 
cell line, after 24 hours of treatment, LC50 and LC100 neared 12.5 µM and 25 µM for 7BIO, respectively. On 
the other hand, 5BIO (25 µM) caused death in approximately the 60% of SH-SY5Y cells treated for 24 
hours [14]. In the present work we have focused more on the time course of the cell death caused by these 
compounds. For instance, we characterized the kinetics of caspase activation. As shown, 5BIO (25 µM) 
displayed a clear time-dependent activation of DEVD-targeting caspases, while 7BIO (25 µM) yielded 
values repeatedly beneath those of control cells (Fig. 1A). Consistently, Q-VD-Oph (10 µM), a chemical 
inhibitor of caspases characterized by its broad spectrum and selectivity for caspase inhibition was not 
modifying the aspect of nuclei in the cells challenged with 7BIO (Fig. 1B). Following a double staining with 
bisBenzimide/PI, fluorescence microscopy showed 7BIO caused the nuclei to have a slightly condensed 
look irrespective of Q-VD-Oph presence. Nuclei became also globular because cells were detached from 
the cultures plates. The caspase-inhibiting activity of Q-VD-Oph was certified by the blockage of the 
apoptotic phenotype observed in 5BIO-treated SH-SY5Y cells (Fig. 1B). Finally, the bisBenzimide/PI 
staining allowed the counting of apoptotic nuclei. As shown, the percentage increased in a time dependent-
manner in 5BIO-treated SH-SY5Y cells. On the opposite, the ratios never surpassed those of untreated, 
time 0, in 7BIO-treated cells (Fig. 1C). In conclusion, for further experiments 5BIO was used to induce 
apoptosis as the closest relative of 7BIO. However, cell death by 7BIO became the subject of our research. 
 Electron microscopy was the first approach to gain insight into the type of cell death triggered by 
7BIO. For this purpose, SH-SY5Y cells were fixed and studied at different times following a treatment with 
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25 µM 7BIO. Control untreated cells displayed a rounded morphology with a large nucleus containing a 
diffuse euchromatin and, often, two ostensible nucleoli (Fig. 2A). In the cytoplasm, endoplasmic reticulum 
was poorly developed and an enlarged Golgi apparatus was frequently seen. Mitochondria displayed 
discernible cristae (Fig. 2C). Following a 3 hours treatment, the most prominent trait was endoplasmic 
reticulum dilation. Interestingly, nuclear envelop was generally spared from dilating (Fig. 2B). Mitochondria 
were also damaged displaying a swelled look and disrupted cristae. Small, medium and large size dilations 
of the reticulum could be observed and regarded as progressive phases of injury. Similarly, different stages 
of mitochondrial cristae disruption could be seen in a cell (Fig. 2D). By 9 hours of treatment, we were 
surprised to realize cytoplasm had disintegrated and most cells converted into isolated nuclei (Fig. 2E). In 
spite of the complete cytoplasm destruction, nuclear integrity was remarkable. At 9 hours or later times, a 
minor proportion of cells could be still observed retaining the cytoplasm. Interestingly, in these cells, 
autophagic multi-lamellar structures were persistently found (Fig. 2F).  
 Jurkat cells were chosen, as a second cell line to investigate 7BIO mode of action, mainly because 
of their non-adherent growth in culture and the subsequent simplicity to perform flow cytometry 
determinations. The death kinetics of Jurkat cells challenged with 7BIO was found to reproduce that of SH-
SY5Y (Fig. 3A). Dead cells began to appear between 3 and 6 hours of treatment. After 12 hours, almost all 
the cell membranes had lost their impermeability. The process in Jurkat cells was also independent of 
caspases, as evidenced by the null effect of Q-VD-Oph on cell death ratios (Fig. 3B). Upon a 7BIO 
treatment and electron microscopy, Jurkat cells displayed a morphological pattern of cell death identical to 
the one just reported in SH-SY5Y cells.  Four additional cell lines (HL-60, MCF-7, IMR-5 and IMR-32) were 
also characterized and reproduced this death pattern when treated with 7BIO (not shown). 
 
3.2. 7BIO-induced cell death and the decrease of ∆Ψm is not mediated by either Bax or Bak proteins 
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The previous morphological studies suggested 7BIO was causing an early effect on mitochondria. This fact 
and the central role of mitochondria in many cell death processes, prompted us to explore the involvement 
of this organelle in 7BIO deadly effects. The dilation of mitochondria has been correlated with the loss of 
mitochondrial membrane potential (∆Ψm), therefore we characterized this parameter by means of the 
DiOC6(3) fluorochrome and flow cytometry. DiOC6(3) is a membrane-permeable reagent that accumulates 
in healthy mitochondria displaying physiological values of ∆Ψm. The reduction ∆Ψm implies a decrease of 
the cell fluorescence. A decreased fluorescence was found after a treatment with 7BIO (25 µM) for 9 hours, 
either in SH-SY5Y or in Jurkat cells (Fig. 4A).  
 In the apoptotic models of cell death, mitochondrial damage is mediated by the proapoptotic 
members of the Bcl-2 family of proteins, essentially Bax and Bak. We wondered what the lethality of 7BIO 
would be if tested on cells not expressing Bax and Bak proteins. Therefore, we proceeded to compare the 
effects of 7BIO on mouse embryonic fibroblasts (MEFs), either w.t. or double Bax-/- Bak-/-. The MTS 
reduction procedure was employed to determine the percentage of cell viability (not shown). The LDH 
release procedure was used to quantify the percentages of cell death (Fig. 4B). Both approaches yielded 
consistent and complementary results. Precisely, 7BIO was inducing the death of both types of MEFs in the 
same range of concentrations and in a concentration-dependent manner. Consequently, the absence of 
Bax and Bak proteins did not confer any cell resistance to the 7BIO compound. On the other hand, as 
expected from cells defective in Bax and Bak, Stauroporine (STS) was not able to trigger apoptosis in these 
cells. Next, we explored the effects of double Bax/Bak deficiency on ∆Ψm dissipation by 7BIO (Fig. 4C). 
The result was that ∆Ψm collapsed only after 3 hours of treatment and double Bax/Bak deficiency was 
neither minimizing nor significantly delaying the collapse. Finally, we were concerned about the null 
expression of Bax and Bak modifying the death phenotype caused by 7BIO. Consequently, we decided to 
perform electron microscopy studies on w.t. and double Bax-/-Bak-/- MEFs under 7BIO treatment (Fig. 5). 
The progressive dilation of the endoplasmic reticulum leading to cytoplasm disintegration and cell death 
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was detected in both types of MEFs. In conclusion, Bax and Bak proteins were not required for 7BIO to kill 
the cells. 
 
3.3. 7BIO-induced loss of ∆Ψm was not counteracted by inhibitors of the MPTP  
Once Bax and Bak protein were discarded as elements mediating 7BIO effects on cell viability and ∆Ψm, 
we focused on the role played by the mitochondrial permeability transition pore (MPTP). The adenosine 
nucleotide translocator (ANT) is the inner mitochondrial component of the channel regulating ∆Ψm. 
Bongkrekic acid (BKKA) is a chemical agent able to block ANT opening and to counteract ∆Ψm loss [19]. 
Similarly, by acting on ANT-associated cyclophilin D, Cyclosporin A (CsA) is able to neutralize ANT-
mediated ∆Ψm loss [20]. The protective effect of both compounds was assayed on SH-SY5Y and Jurkat 
cells challenged with 7BIO. We found no rescue effect either on cell death or on ∆Ψm dissipation by the 
presence of either 50 µM BKKA or 2 µM CsA in the culture medium (Fig. 6). Next, we thought of the 
possibility that 7BIO could have a double mode of action consisting of Bax and/or Bak activation plus MPTP 
opening. This would mean one mechanism of ∆Ψm loss being able to compensate for the blockage of the 
other. This caveat led us to test the effects of BKKA and CsA on double Bax-/-Bak-/- MEFs (Fig. 7).  
Moreover, we tested BKKA plus CsA added together on Bax-/-Bak-/- MEFs facing 7BIO (not shown). In all 
experimental conditions, neither cell death nor ∆Ψm loss was meaningfully reduced. In conclusion, MPTP-
inhibiting agents were not able to antagonize 7BIO-induced ∆Ψm collapse and the null role of Bax and Bak 
proteins was further reinforced. 
 
3.4. Neither AIF translocation nor DNA degradation were detected in cells treated with 7BIO  
AIF (Apoptosis Inducing Factor) is a flavoprotein that is located in the mitochondria and which functional 
activity is characterized by being double and opposed [21]. If placed at the mitochondrial inner membrane, 
AIF displays cytoprotective actions. Upon mitochondrial outer membrane permeabilization, its translocation 
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seems to be responsible for many of the caspase-independent traits of apoptosis. Consequently, we 
considered mandatory to explore the putative involvement of AIF in the lethal effects of 7BIO. We 
proceeded to determine if AIF became present in the cytosol upon a treatment with 7BIO. SH-SY5Y (Fig. 
8A) and Jurkat (not shown) cells were fractioned as reported in the materials and methods section and the 
AIF content in the cytosolic and mitochondrial fractions was determined by Western Blot. As shown, AIF 
remained in the mitochondrial fraction along the dying process triggered by 7BIO. As a positive control of 
AIF translocation, we used the apoptosis-inducing 5BIO compound. As expected, 5BIO caused AIF release 
from mitochondria in the cells undergoing apoptosis. In addition, we explored the degradation of cell 
chromatin (Fig. 8B). 5BIO treatment caused the apoptotic laddering of DNA while 7BIO was not producing 
this low molecular weight type of chromatin degradation, in agreement with a previous report [14]. Next we 
studied the high molecular weight fragmentation of chromatin, which was clearly observed in cells treated 
with 5BIO but absent from 7BIO-treated ones. In conclusion, these fragmentation patterns are distinctive 
traits of apoptosis but are not found in 7BIO-induced cell death. Moreover, the overall integrity of DNA is 
consistent with the preserved morphology of nuclei and chromatin observed in the previous ultrastructural 
studies. 
 
3.5. 7BIO was not triggering calpain- or cathepsin-type protease activity  
Calpain and cathepsin, like caspases, are cysteine proteases which activation has been implicated in the 
necrotic type of cell death [7, 8]. Therefore, we proceeded to analyze their involvement in the death process 
triggered by 7BIO. First we tested the effect of several pharmacological inhibitors of these enzymes on SH-
SY5Y and Jurkat cells. Calpeptin is known to be an inhibitor of calpain and cathepsin L proteases. zFAfmk 
is an inhibitor of cathepsins B and L. Leupeptin inhibits cathepsins A and B among other cysteine plus 
serine proteases included in its spectrum. Finally, zVADfmk is a general inhibitor of caspases with the ability 
to inhibit other cysteine proteases, for instance calpains and cathepsins, at a concentration of 100 µM [22]. 
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The specific capase inhibitor Q-VD-Oph, that is unable to inhibit calpains and cathepsins, was used as a 
control. In a summary, the presence of these inhibitors did not change the ratios of cell lethality caused by 
7BIO (Fig. 9A). In addition, calpain activity was assessed directly by means of a fluorescence-releasing 
substrate (Fig. 9B). The increase of calpain activity detected in SH-SY5Y cells challenged with 7BIO was 
negligible. Cathepsin activation was also checked by an analogous approach in Jurkat cells treated with 
7BIO (Fig. 9C). While 5BIO treatment activated cathepsins significantly, 7BIO displayed activation values 
undistinguishable from untreated cells. In conclusion, neither calpains nor cathepsins seemed engaged in 
the 7BIO mode of action. 
 
3.6. The activity of serine proteases was involved in 7BIO-induced cell death  
In order to find a molecular event actively involved in the 7BIO mechanism of cell killing, we decided to 
perform a broad pharmacological screening. We searched for a compound or family of compounds with the 
ability to revert the death process, either stopping or significantly delaying it. Based on the results described 
before, 9 hours was considered the optimal time point for the detection of a putative protective effect. The 
SH-SY5Y cells and the MTS procedure were chosen to perform the screening. Substances able to prevent 
cell oxidative stress or calcium overload, like N-Acetylcysteine, Nifedipine, BAPTA AM and Ruthenium Red 
were combined with 7BIO, but did not modify the cell death process. Proteasome inhibitors like Lactacystin 
and Bortezomib were also tested and did not reverse 7BIO lethality. Finally, 3-methyladenine and 
necrostatin-1, as pharmacological inhibitors of autophagy [23] and necroptosis [24] respectively, failed to 
antagonize 7BIO toxicity (not shown). Among all the chemicals tested, some serine protease inhibitors were 
those with the most remarkable ability to block the cell death process in both, SH-SY5Y and Jurkat cell lines 
(Fig. 10A). These compounds are chemically unrelated and share the property of inhibiting serine 
proteases. Therefore, the involvement of a serine protease activity, which is inhibited by TPCK, DCI and, 
particularly, the AEBSF compound but not TLCK, was concluded. 
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 AEBSF continued to protect the cells from 7BIO after 24 hours of treatment, although to a lesser 
extent than at 9 hours (not shown). When times longer than 24 hours were analyzed, AEBSF intrinsic 
lethality impaired any solid conclusion (not shown). To better characterize the AEBSF protective effect, we 
determined ∆Ψm in Jurkat cells challenged with 7BIO and 7BIO plus AEBSF (Fig. 10B).  These 
experiments revealed ∆Ψm loss as soon as 2 hours after 7BIO treatment, thus indicating again a very initial 
mitochondrial injury. Furthermore, AEBSF was clearly demonstrating a protective effect on mitochondria. In 
conclusion, we propose the involvement of the proteolytic activity of at least one, yet undetermined, serine 
protease in the 7BIO mode of action. 
 
 
4. Discussion 
The new indirubin derivative 7BIO has demonstrated to be a fast and efficient cell killer in all the cell lines 
we have tested so far. The death process is characterized by being caspase-independent and, accordingly, 
not to show apoptotic features like typical nuclear condensation plus fragmentation, DNA laddering or 
cytochrome c translocation to the cytoplasm. In addition, we have proved the process not to be mediated by 
p53 and to be insensitive to either Bcl-2 or Bcl-XL proteins [14]. In this report we have attempted to gain 
insight into the cell death process caused by 7BIO. Electron microscopy provided evidence of an identical 
morphological pattern, irrespective of the cell type studied. The pattern consisted of early mitochondrial 
swelling and cristae disruption, progressive dilation of the endoplasmic reticulum and final destruction of the 
cytoplasm yielding isolated nuclei with a remarkable preserved structure. Though a diffuse increase in 
chromatin condensation could be observed, it was different from the peripheral, AIF-mediated stage-1 type 
[25]. In agreement, a kinetic analysis of AIF protein translocation ruled out AIF participation. Moreover, the 
release of AIF from mitochondria is known to require either calpain or cathepsin activation [22, 26]. 
Consistently, neither calpain nor cathepsin protease activity was triggered in cells by the 7BIO action. 
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 The observation of injured mitochondria early in the death process prompted us to focus on ∆Ψm 
disruption, as a representative parameter of the mitochondrial function. In Jurkat cells we found ∆Ψm 
decreased as soon as 2 hours following 7BIO treatment. This was in accordance with the timing observed 
for the morphological disruption of mitochondria. The collapse of ∆Ψm can be caused by either Bax/Bak 
protein activation or the MPTP opening [27]. Therefore, double Bax-/-Bak-/- MEFs were studied and a null 
involvement of both proteins was found.  CsA and BKKA are two chemical agents with the ability to block 
the opening of the ANT component of the MPTP [19, 20]. Neither was able to prevent cell death or ∆Ψm 
disruption in the four cell lines tested, SH-SY5Y, Jurkat, w.t. and double Bax-/-Bak-/- MEFs. The fact that 
CsA and BKKA acting on Bax-/- Bak-/- MEFs made no difference, allowed to discard 7BIO might 
simultaneously act on two different targets Bax/Bak proteins and the MPTP. However, in relation to MPTP 
involvement, nothing could be definitively concluded. Even though the reversion of ∆Ψm disruption by CsA 
and BKKA suggests the involvement of the MPTP, a negative result cannot be interpreted as proving its 
non-involvement. MPTP could be activated by a yet undiscovered mechanism triggered by 7BIO and 
insensitive to the effects of CsA and BKKA. For example, a hypothetical mechanism not mediated by ANT, 
the target of both CsA and BKKA. In addition, the possibility of an MPTP-independent mechanism could be 
envisaged as the cause of ∆Ψm disruption. 
 What is the molecular target for 7BIO? The bis-indole structure of 7BIO suggests an ATP competing 
action and, therefore, protein kinases are the first target candidates. However, up to date, 85 protein 
kinases have been studied and discarded as responsible for this type of cell death [14]. Alternatively, we are 
thinking of exploring the elements constituting the mitochondrial respiratory chain as possible targets. The 
disruption of mitochondrial respiration is a good hypothesis for an MPTP-independent mechanism to disrupt 
∆Ψm. On the other hand, in 7BIO triggered cell death, we have identified the involvement of a protease 
activity which is characterized by its sensitivity to serine protease inhibitors and, particularly, to AEBSF. 
AEBSF is a chemical inhibitor of serine proteases and several apoptotic features are known to be 
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neutralized by this compound [28, 29]. Long ago, we described the ability of TLCK, a trypsin-like protease 
inhibitor, to inhibit cycloheximide-induced cell death in N18, a mouse neuroblastoma cell line [30]. 
Interestingly, N18 cells underwent an unusual vacuolated type of apoptosis facing the inhibition of new 
protein synthesis with cycloheximide. Other authors have identified TLCK sensitive serine proteases in 
apoptosis and named them serpases [31]. However, none of these reports were dealing with a necrotic type 
of cell death like the one triggered by 7BIO. Moreover, our results show no involvement of a TLCK sensitive, 
trypsin-like, serine protease and, instead, point to a TPCK sensitive, chymotrypsin-like, one. Such an 
activity has been described in the proteasome and DCI compound is known to be a proteasome inhibitor at 
the concentration we have used. Since specific inhibitors of the proteasome did not modify 7BIO-induced 
lethality, we do not support a role for proteasome activation in the 7BIO mode of action. 
 There is a general agreement not to create a plethora of names to identify processes of cell death 
with specific features [3]. For instance, we were very cautious not to propose a name for an atypical cell 
death process that ended up being a defective type of apoptosis caused by the absence of CAD, the 
Caspase-Activated DNAse protein [32]. Concerning 7BIO-triggered death process, we propose to consider 
it a specific type of necrosis. Based on this report results and those previously published [14], we believe 
there is sufficient evidence to no longer suspect that 7BIO-type of cell death is a defective phenotype of 
apoptosis. Is it autophagic cell death? Indeed, autophagy has been observed in the cell corpses but its role 
in causing cell death is doubtful. First, autophagy seems not to be present in most cells. Second, in 7BIO 
challenged cells, we have assayed 3-methyladenine at concentrations able to block autophagy [23]. Neither 
a rescue nor a deleterious effect was found. Third, Bcl-2 is known to prevent autophagic cell death by it 
ability to neutralize the protein Beclin [33]. We have reported the null effect of Bcl-2 overfunction on the 
7BIO lethal effects [14]. These facts strongly support our doubts about autophagy being the 7BIO mode of 
cell killing. Autophagy has been defined as a cell death process not necessarily caused by autophagy but 
with autophagy being present [3]. Based on this definition, we could define as autophagic the cell death 
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process triggered by 7BIO. However, we do not favor this option. First, as just mentioned, autopahgy seems 
not to affect the entire cell population. Second, we believe the nomenclature of a cell death type should be 
as informative as possible about the mechanisms leading to it. In conclusion, we prefer to maintain the term 
necrosis (Type III cell death) to define the 7BIO-induced death process.  
 Recently, a lot of interest has been raised by several paradigms of necrosis as molecularly 
regulated processes of cell death. In these paradigms, cyclophilin D, calpains and cathepsins are expected 
to have a determinant role [7-10] However, in the present report, their involvement has been ruled out. 
Furthermore, the lack of cathepsin activation precludes the involvement of the lysosomes and a lysosomal-
type cell death. The cell ultrastructure caused by 7BIO evoked a cell death process observed in embryonic 
development and named cytoplasmic type [2]. However, any relationship with the 7BIO induced death 
process is merely speculative. Unless the embryonic process can be transferred, for example, to cell 
culturing conditions to allow molecular analyses, it will be very difficult to find a potential correlate. This is 
why we have not used cytoplasm disintegration or cytoplasmic type as a very suitable nomenclature for the 
7BIO-induced cell death. Several models of atypical cell death have been described so far. Paraptosis is 
characterized by caspase 9 activation and a late occurrence of mitochondria swelling [34], therefore it is 
clearly different from the 7BIO-trigered process. Necroptosis displays distinctive features of necrosis and 
autophagy very similar to the ones we have described here [24]. The death preventive effect of necrostatin-
1 is what allows the identification of necroptosis experimentally, but necrostatin-1 has not protected cells 
from the 7BIO challenge. In conclusion, 7BIO triggers a necrotic process with a combination of original 
traits. We propose 7BIO reveals a specific paradigm of necrotic cell death.  
 7BIO is a new chemical agent with a great toxicity on cells in culture conditions, either proliferating 
or in a quiescent differentiated state [14]. In this report, 7BIO displays the ability to kill cells totally resistant 
to apoptosis through the intrinsic pathway. Therefore, a therapeutic potential for apoptosis-resistant cancer 
can be suggested. However, many questions remain. What is the target of 7BIO and how is it causing cell 
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death? Is 7BIO engaging a physiological mechanism of cell death or is it accidental? What the toxicity of 
7BIO will be when assayed in an animal model? These caveats notwithstanding, 7BIO is already a 
challenging compound for necrobiologists, presently available for further research. 
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Figure Legends 
Fig. 1 - Characterization of the cell death process induced in SH-SY5Y cells by the 5BIO and 7BIO 
compounds. (A) SH-SY5Y cells were treated for the times indicated in the graph with 25 µM 5BIO, 25 µM 
7BIO or 0.5% DMSO, which was used as the vehicle of the BIO compounds. Then, DEVD-targeted caspase 
activity was determined. Average ± Standard Error of Media (SEM) of three determinations is shown. (B) 
SH-SY5Y cells were treated for 9h with 25 µM 5BIO, 25 µM 7BIO or left untreated. In identically treated 
cultures, 10 µM Q-VD-Oph was added. A double direct staining with bisBenzimide and PI was performed 
and cells were subjected to fluorescence microscopy. Scale bar equals 20 µm. (C) SH-SY5Y cells were 
treated as indicated in the figure to determine the time-course of apoptosis induction. Following 
bisBenzimide staining, fluorescence microscopy allowed the counting of apoptotic nuclei. Only those 
displaying unmistakable traits of apoptosis were counted. Bar value is the mean ± SEM of two independent 
experiments with a minimal of 200 cells counted per condition. 
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Fig. 2 - Electron microscopy of the cell death process induced in SH-SY5Y cells by the 7BIO 
compound. (A) Control untreated SH-SY5Y cells. The Golgi apparatus, G, and mitochondria, m, are 
indicated. (B) SH-SY5Y cells treated for 3 hours with 25 µM 7BIO. In the centrally displayed cell, 
arrowheads point to dilations of the endoplasmic reticulum (medium size dilations). In a neighboring cell, an 
arrowhead is used to mark a greater size dilation of the reticulum. A cluster of mitochondria, m, further 
shown at greater magnification is indicated. (C) The Golgi apparatus, G, and mitochondria, m, of the healthy 
cell, above, are shown at greater magnification. A detail of the nuclear envelope and chromatin, N, is also 
shown. (D) At greater magnification, the mitochondrial cluster, m, indicated above. The cluster shows 
different stages of the disruption caused by 7BIO. As previously, the arrowhead points to the endoplasmic 
reticulum dilations. Here, the small size dilations are emphasized. (E) SH-SY5Y cells treated for 9 hours 
with 25 µM 7BIO. Two preserved and isolated nuclei, N, surrounded by subcellular debris are seen. (F) SH-
SY5Y cells treated for 12 hours with 25 µM 7BIO. Arrows point to autophagosomes. The nucleus, N, and 
mitochondria, m, can be identified. Many independent cells were characterized by electron microscopy at 
the time points reported before. The selected images are representative of traits observed reproducibly. 
 
Fig. 3 - Characterization of the cell death process induced in Jurkat cells by the 7BIO compound. (A) 
SH-SY5Y and Jurkat cells were treated with 25 µM 7BIO and cell death was quantified at the times shown 
in the x-axis. In SH-SY5Y, the Trypan Blue procedure was employed to assess cell death ratios. In non-
adherent Jurkat cells, PI staining and flow cytometry was preferred. Irrespective of the method, three 
independent experiments and three independents counts were done. Bar value is the calculated mean ± 
SEM. (B) SH-SY5Y and Jurkat cells were also treated for 9 hours with either 25 µM 7BIO or 25 µM 7BIO 
plus 10 µM Q-VD-Oph to ascertain an eventual involvement of caspases in Jurkat cell death. The effects of 
Q-VD-Oph and the DMSO vehicle alone were also tested. Cell death was determined and calculated as 
before.  
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Fig. 4 - Effects of 7BIO on ∆Ψm. (A) SH-SY5Y and Jurkat cells were treated with 7BIO (25 µM) or the 
DMSO vehicle as stated in the figure. Then, ∆Ψm was determined by means of the DiOC6(3) reagent. The 
displayed histograms are representative of several independent experiments. (B) Double Bax-/-Bak-/- and 
w.t. MEFs were treated for 24 hours with 7BIO and STS as reported in the x-axis. Cell death (%) was 
measured by means of the LDH release procedure. LDH determination of STS treatment was performed at 
48 hours. Average ± SEM of at least two independent experiments with three independent measurements 
per experiment are shown. (C) Double Bax-/-Bak-/- and w.t. MEFs were treated with 7BIO (25 µM) as 
indicated in the figure and ∆Ψm was determined as before. Reproducible results were obtained in several 
independent experiments. 
 
Fig. 5 - Examination by electron microscopy of MEFs treated with 7BIO. (A) Ultrastructure of control, 
untreated, w.t. MEFs. (B,C) The w.t. MEFs treated with 7BIO (25 µM) for 9 hours. (D) Ultrastructure of 
double Bax-/-Bak-/- MEFs untreated. (E) Bax-/-Bak-/- MEFs challenged with 7BIO (25 µM) for 3 hours. (F) 
Bax-/-Bak-/- MEFs treated with 7BIO (25 µM) for 9 hours. Arrowheads are used to emphasize great size (in 
B) and medium size (in E) dilations of the endoplasmic reticulum. Isolated and well preserved nuclei, N, 
characterize the later phases of the process. The images shown are representative of the morphologies 
observed. 
 
Fig. 6- Effects on ∆Ψm of SH-SY5Y and Jurkat cells treated with 7BIO plus inhibitors of MPTP 
opening. SH-SY5Y and Jurkat cells were treated for 9 hours as stated in the figure. The concentrations 
were 25 µM for 7BIO, 50 µM for BKKA and 2 µM for CsA. Following a double staining with DiOC6(3) and PI 
as described in the methods section, cells were collected and subjected to flow cytometry. FL-1 (DiOC6(3)) 
registered events are plotted on the y-axis. FL-3 (PI) registered events are plotted on the x-axis. The 
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reduction of ∆Ψm plus cell membrane rupture is detected as a migration from the upper left quadrant to the 
lower right one. The biparametric plots displayed are representative of at least two independent 
experiments. 
 
Fig. 7- Effects on ∆Ψm of double Bax-/-Bak-/- and w.t. MEFs treated with 7BIO plus inhibitors of 
MPTP opening. Double Bax-/-Bak-/- and w.t. MEFs were treated for 9 hours as stated in the figure. The 
concentrations were 25 µM for 7BIO, 50 µM for BKKA and 2 µM for CsA. Cells were stained and analyzed 
by flow cytometry as described in the previous figure. The biparametric plots displayed are representative of 
at least two independent experiments. 
 
Fig. 8 - AIF translocation and DNA degradation analysis of SH-SY5Y cells treated with 7BIO. (A) SH-
SY5Y cells were treated with 7BIO (25 µM) for the times indicated in the figure, 5BIO (25 µM) for 9 hours, 
or the DMSO vehicle. Cells were fractionated into a cytosolic (Cyt.) and a mitocondrial-containing fraction 
(Mit.), as reported in the materials and methods section. The content of AIF (62 kDa) in the fractions was 
detected by means of Western Blotting. tAIF (57 kDa) states for truncated AIF, the form of AIF released 
from mitochondria upon a protease cleavage. (B) SH-SY5Y cells were treated for 24 hours as stated in the 
figure. The concentration of 7BIO and 5BIO was 25 µM. DNA laddering was studied by means of 
electrophoresis in 1.5% agarose gels. High molecular DNA fragmentation was analyzed by means of 
agarose gels and CHEF electrophoresis. 
 
Fig. 9 - Calpain- and cathepsin-type proteases are not involved in the 7BIO-trigered process of cell 
death.  (A) SH-SY5Y and Jurkat cells were incubated with the protease inhibitors indicated in the figure for 
half an hour and, then, treated with 7BIO. Cell death was determined after 9 hours of coincubation by 
means of Trypan blue (SH-SY5Y) or PI staining (Jurkat). The percentages displayed are the mean ± SEM 
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of three independent counts and three independent experiments. (B) SH-SY5Y cells were treated for 9 
hours with STS (1 µM) or 7BIO (25 µM) and calpain activity was quantified by means of a fluorescent 
substrate. Bar value in arbitrary fluorescent units is the mean ± SEM of five independent experiments. (C) 
Jurkat cells were treated for 9 hours with STS (1 µM), 5BIO (25 µM) and 7BIO (25 µM) and cathepsin 
activity was determined by means of a fluorescent substrate. Values in arbitrary fluorescent units are the 
average ± SEM of five independent experiments. 
 
Fig. 10 - Inhibitors of serine proteases protect cells from the challenge of 7BIO. (A) SH-SY5Y and 
Jurkat cells were treated for 9 hours with 7BIO, 7BIO plus Q-VD-Oph or several serine protease inhibitors 
as stated in the figure. The percentage of cell death was obtained by the Trypan blue (SH-SY5Y) and PI 
(Jurkat) procedures, as reported in the methods section. The percentages displayed are the mean ± SEM 
of three independent counts and three independent experiments. (B) Jurkat cells were treated with 25 µM 
7BIO (white bars) or 25 µM 7BIO plus 300 µM AEBSF (grey bars) and the percentage of cells with a 
marked reduction in the fluorescence of DiOC6(3) was calculated at different time points. The average ± 
SEM of three independent experiments is displayed.  
 
 
 
  
 30
 
 
Fig. 1. 
 
 
 31
Fig. 2. 
 
 
 32
Fig. 3. 
 
 
 
 
  
 33
Fig. 4. 
 
  
 34
Fig. 5. 
 
 
 
  
 35
Fig. 6. 
 
 
 
 
  
 36
Fig. 7. 
 
  
 37
Fig. 8. 
 
 
 
 
 
 
  
 38
Fig. 9. 
 
  
 39
Fig. 10. 
 
 
